Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,918 public trials 501 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

NCT00970307

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Dębica, Poland
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 75 locations
View Trial Details
Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
View all 63 locations
View Trial Details
Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Vista, California, United States
View all 40 locations
View Trial Details
Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

NCT00359619

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
View Trial Details
Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

NCT00250276

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Hvidovre, Denmark
  • GSK Investigational Site Kaunas, Lithuania
  • GSK Investigational Site Klaipėda, Lithuania
  • GSK Investigational Site Vilnius, Lithuania
View Trial Details
Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

NCT00003196

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • Universitaet Leipzig Leipzig, Germany
View Trial Details

Related conditions